66 related articles for article (PubMed ID: 7984661)
21. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
[TBL] [Abstract][Full Text] [Related]
22. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
23. Effect of quinolinic acid (QUIN) on gamma-aminobutyric acid concentration in the rat brain.
Smiałek M; Kittel M
Neuropatol Pol; 1988; 26(3):423-9. PubMed ID: 2978172
[No Abstract] [Full Text] [Related]
24. Intact intracortical microstimulation (ICMS) representations of rostral and caudal forelimb areas in rats with quinolinic acid lesions of the medial or lateral caudate-putamen in an animal model of Huntington's disease.
Karl JM; Sacrey LA; McDonald RJ; Whishaw IQ
Brain Res Bull; 2008 Sep; 77(1):42-8. PubMed ID: 18639744
[TBL] [Abstract][Full Text] [Related]
25. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
[TBL] [Abstract][Full Text] [Related]
26. Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain.
Vécsei L; Miller J; MacGarvey U; Beal MF
Brain Res Bull; 1992 Feb; 28(2):233-8. PubMed ID: 1596743
[TBL] [Abstract][Full Text] [Related]
27. Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model.
Knyihár-Csillik E; Toldi J; Mihály A; Krisztin-Péva B; Chadaide Z; Németh H; Fenyo R; Vécsei L
J Neural Transm (Vienna); 2007; 114(4):417-21. PubMed ID: 16897600
[TBL] [Abstract][Full Text] [Related]
28. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
29. Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats.
Block F; Kunkel M; Schwarz M
Neurosci Lett; 1993 Jan; 149(2):126-8. PubMed ID: 8474683
[TBL] [Abstract][Full Text] [Related]
30. The Janus faces of 3-hydroxykynurenine: dual redox modulatory activity and lack of neurotoxicity in the rat striatum.
Colín-González AL; Maya-López M; Pedraza-Chaverrí J; Ali SF; Chavarría A; Santamaría A
Brain Res; 2014 Nov; 1589():1-14. PubMed ID: 25251594
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms by which acyclovir reduces the oxidative neurotoxicity and biosynthesis of quinolinic acid.
Müller AC; Dairam A; Limson JL; Daya S
Life Sci; 2007 Feb; 80(10):918-25. PubMed ID: 17174341
[TBL] [Abstract][Full Text] [Related]
32. [The effect of kynurenine and quinolinic acid on autonomic and behavioral reactions in dogs].
Pastukhov VA
Fiziol Zh SSSR Im I M Sechenova; 1991 Feb; 77(2):116-9. PubMed ID: 1652507
[No Abstract] [Full Text] [Related]
33. Effect of taurine on the concentrations of glutamate, GABA, glutamine and alanine in the rat striatum and hippocampus.
Molchanova SM; Oja SS; Saransaari P
Proc West Pharmacol Soc; 2007; 50():95-7. PubMed ID: 18605241
[TBL] [Abstract][Full Text] [Related]
34. Time- and dose-dependent 45Ca2+ accumulation in rat striatum and substantia nigra after an intrastriatal injection of quinolinic acid.
Gramsbergen JB; van der Sluijs-Gelling AJ
Exp Neurol; 1993 Jun; 121(2):261-9. PubMed ID: 8339777
[TBL] [Abstract][Full Text] [Related]
35. Spermine attenuates behavioral and biochemical alterations induced by quinolinic acid in the striatum of rats.
Velloso NA; Dalmolin GD; Fonini G; Gindri Sinhorin VD; Ferreira da Silveira A; Rubin MA; Mello CF
Brain Res; 2008 Mar; 1198():107-14. PubMed ID: 18243165
[TBL] [Abstract][Full Text] [Related]
36. The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity.
Orlando LR; Alsdorf SA; Penney JB; Young AB
Exp Neurol; 2001 Jan; 167(1):196-204. PubMed ID: 11161608
[TBL] [Abstract][Full Text] [Related]
37. 6-Hydroxymelatonin protects against quinolinic-acid-induced oxidative neurotoxicity in the rat hippocampus.
Maharaj DS; Maharaj H; Antunes EM; Maree DM; Nyokong T; Glass BD; Daya S
J Pharm Pharmacol; 2005 Jul; 57(7):877-81. PubMed ID: 15969947
[TBL] [Abstract][Full Text] [Related]
38. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
Vazey EM; Chen K; Hughes SM; Connor B
Exp Neurol; 2006 Jun; 199(2):384-96. PubMed ID: 16626705
[TBL] [Abstract][Full Text] [Related]
39. Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus.
Wu HQ; Lee SC; Schwarcz R
Eur J Pharmacol; 2000 Mar; 390(3):267-74. PubMed ID: 10708733
[TBL] [Abstract][Full Text] [Related]
40. Temporal profile of subventricular zone progenitor cell migration following quinolinic acid-induced striatal cell loss.
Gordon RJ; Tattersfield AS; Vazey EM; Kells AP; McGregor AL; Hughes SM; Connor B
Neuroscience; 2007 Jun; 146(4):1704-18. PubMed ID: 17459592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
